EICHORCondition: Systemic Mastocytoses, Indolent · Systemic Mastocytoses, Aggressive · Sponsor: Cogent Biosciences, Inc.
The purpose of this expanded access program (EAP) protocol is to provide investigational bezuclastinib to patients with a diagnosis of nonadvanced systemic mastocytosis (NonAdvSM) or advanced systemic mastocytosis (AdvSM) who have received and failed or been intolerant to at least one standard approved therapy and/or have no comparable or satisfactory alternative therapy options.
This description comes directly from the study's public registry record.
Alexandra Malinowski, PharmD · 1-877-633-8049 · EAP@cogentbio.com
Always discuss trial participation with your own doctor first.
| Orso Health/Modena Asthma Allergy | La Jolla, California, United States | Available |
| Scripps Green Hospital | La Jolla, California, United States | Available |
| UCLA Ronald Reagan Medical Center | Los Angeles, California, United States | Available |
| Sneeze Wheeze & Itch Associates LLC Clinical Research Center | Normal, Illinois, United States | Available |
| Indiana University Health | Indianapolis, Indiana, United States | Available |
| Northern Light Eastern Maine Medical Center | Bangor, Maine, United States | Available |
| Walter Reed | Bethesda, Maryland, United States | Available |
| AllerVie Health | Glenn Dale, Maryland, United States | Available |
| Boston Specialists | Boston, Massachusetts, United States | Available |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Available |
| Michigan Medicine- University of Michigan | Ann Arbor, Michigan, United States | Available |
| Mayo Clinic | Rochester, Minnesota, United States | Available |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915766